### Response:

1. **Check the HIPAA regulation IDs (164.502(d)(1), 164.502(a)(5)(ii)(B)) and their content:**

- **164.502(d)(1):** This section of the HIPAA Privacy Rule pertains to the standard for uses and disclosures of de-identified protected health information.
  
- **164.502(a)(5)(ii)(B):** This section relates to the permissibility of disclosing protected health information for certain purposes.

2. **Determine whether the HIPAA Privacy Rule permits or forbids the case:**

Based on the information provided in the case, the handling of de-identified prescription information by CVS Caremark Corporation and CVS Pharmacy, Inc. raises concerns regarding compliance with the HIPAA Privacy Rule.

3. **Please use Permit or Forbid to answer:**

The sharing and sale of de-identified patient information by CVS to pharmaceutical companies and third-party data firms **Forbid** under the HIPAA Privacy Rule. This action violates the privacy rights and expectations of the patients involved, as their information was used for purposes beyond their consent and potentially without adequate safeguards.

It is crucial to ensure that patient information, even when de-identified, is handled in accordance with HIPAA regulations to protect individual privacy and maintain trust in the healthcare system.